Pfizer Inc (PFIZ34) — Capital Reinvestment Ratio
Latest as of March 2026:
0.17x
Pfizer Inc (PFIZ34) has a Capital Reinvestment Ratio of 0.17x as of March 2026, meaning it reinvests 0% of its operating cash flow (R$2.62 Billion) in capital expenditures (R$436.00 Million). See PFIZ34 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.17x
Capex / Operating Cash Flow
Operating Cash Flow
R$2.62 Billion
BRL
Capital Expenditures
R$436.00 Million
BRL
Data as of
Mar 2026
Most recent filing
Pfizer Inc Capital Reinvestment Ratio (2014–2025)
This chart tracks Pfizer Inc's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Pfizer Inc (2014–2025)
Year-by-year Capital Reinvestment Ratio for Pfizer Inc from 2014 to 2025. For live market cap and broader valuation context, see market cap of Pfizer Inc.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | R$11.71 Billion | R$2.63 Billion | ▼ -1.6% |
| 2024 | 0.23x | R$12.74 Billion | R$2.91 Billion | ▼ -28.9% |
| 2023 | 0.32x | R$12.04 Billion | R$3.86 Billion | ▲ +190.2% |
| 2022 | 0.11x | R$29.27 Billion | R$3.24 Billion | ▲ +32.9% |
| 2021 | 0.08x | R$32.58 Billion | R$2.71 Billion | ▼ -57.1% |
| 2020 | 0.19x | R$14.40 Billion | R$2.79 Billion | ▼ -6.0% |
| 2019 | 0.21x | R$12.59 Billion | R$2.59 Billion | ▲ +48.5% |
| 2018 | 0.14x | R$15.83 Billion | R$2.20 Billion | ▲ +5.2% |
| 2017 | 0.13x | R$16.80 Billion | R$2.22 Billion | ▲ +6.9% |
| 2016 | 0.12x | R$16.19 Billion | R$2.00 Billion | ▲ +29.8% |
| 2015 | 0.10x | R$14.69 Billion | R$1.40 Billion | ▲ +35.5% |
| 2014 | 0.07x | R$17.08 Billion | R$1.20 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow